An observational study in Sternoclavicular Joint Infection, sponsored by University Hospital, Basel, Switzerland. Completed at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-06-05.
Sponsored by University Hospital, Basel, Switzerland · Observational
The Sternoclavicular joints (SCJ) represents an important factor in stability of shoulder joint. Its influence and its function is important for the functionality of the shoulder. SCJ infection is a rare condition and remains often mistreated and potentially life threatening.
This study is to assess the cases treated at the University Hospital Basel with a surgical approach of extended resection of the SCJ. One prospective follow-up visit inclusive one physical examination per patient will be performed to evaluate the long-term functional results of arm, shoulder, hand function with the QuickDASH questionnaire.
6,687 studies on the registry are indexed under Infections; 807 are open to participants now.
This study's enrollment of 14 is below the median of 240 across 2,136 observational studies indexed under Infections.
Browse Infections studies →University Hospital, Basel, Switzerland is the lead sponsor of 968 studies on the registry; 191 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients diagnosed with SCJ infection and surgical treatment of extended SCJ resection, treated at the Department of Thoracic Surgery at the University Hospital Basel between 31.05.2011 and 28.02.2022.
Exclusion Criteria:
QuickDASH score
QuickDASH score of the mobility of the arm, shoulder, hand and its function by using the QuickDASH questionnaire. The QuickDASH is scored in two components: the disability/symptom section (11 items, scored 1-5) and the optional high performance sport/music or work modules (4 items, scored 1-5). A higher score indicates greater disability.
Time frame: one time assessment at the prospective follow-up visit (timeframe of maximal 1 hour)
This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Basel, Switzerland